AU2003278814A1 - Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof - Google Patents

Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof

Info

Publication number
AU2003278814A1
AU2003278814A1 AU2003278814A AU2003278814A AU2003278814A1 AU 2003278814 A1 AU2003278814 A1 AU 2003278814A1 AU 2003278814 A AU2003278814 A AU 2003278814A AU 2003278814 A AU2003278814 A AU 2003278814A AU 2003278814 A1 AU2003278814 A1 AU 2003278814A1
Authority
AU
Australia
Prior art keywords
ligands
methods
activated receptor
peroxisome proliferator
proliferator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003278814A
Other versions
AU2003278814A8 (en
Inventor
Robert I. Glazer
Alan P. Kozikowski
Pavel Petukhov
Zhi-Liang Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Georgetown University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University filed Critical Georgetown University
Publication of AU2003278814A8 publication Critical patent/AU2003278814A8/en
Publication of AU2003278814A1 publication Critical patent/AU2003278814A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003278814A 2002-09-13 2003-09-12 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof Abandoned AU2003278814A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41067702P 2002-09-13 2002-09-13
US60/410,677 2002-09-13
PCT/US2003/028931 WO2004024939A2 (en) 2002-09-13 2003-09-12 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof

Publications (2)

Publication Number Publication Date
AU2003278814A8 AU2003278814A8 (en) 2004-04-30
AU2003278814A1 true AU2003278814A1 (en) 2004-04-30

Family

ID=31994180

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003278814A Abandoned AU2003278814A1 (en) 2002-09-13 2003-09-12 Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof

Country Status (2)

Country Link
AU (1) AU2003278814A1 (en)
WO (1) WO2004024939A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004113331A1 (en) 2003-06-20 2004-12-29 Galderma Research & Development, S.N.C. Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions
GB0403864D0 (en) * 2004-02-20 2004-03-24 Ucl Ventures Modulator
WO2005113519A1 (en) 2004-05-14 2005-12-01 Irm Llc Compounds and compositions as ppar modulators
ATE534646T1 (en) * 2004-10-29 2011-12-15 Zeria Pharm Co Ltd CARBAZOLE DERIVATIVE, SOLVATE THEREOF AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
FR2878247B1 (en) 2004-11-19 2008-10-03 Galderma Res & Dev NOVEL MODULATING COMPOUNDS OF PPARY RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
WO2006053791A2 (en) * 2004-11-19 2006-05-26 Galderma Research & Development Compounds that modulate ppary type receptors, and use thereof in cosmetic or pharmaceutical compositions
AR060901A1 (en) * 2006-05-12 2008-07-23 Jerini Ag HETEROCICLICAL COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE OF THESE
AU2007307597A1 (en) 2006-10-12 2008-04-17 Institute Of Medicinal Molecular Design. Inc. Carboxylic acid derivatives
EP2272817A4 (en) * 2008-04-11 2011-12-14 Inst Med Molecular Design Inc Pai-1 inhibitor
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
ES2781401T3 (en) 2008-11-19 2020-09-01 Pola Chem Ind Inc Anti-wrinkle agents
WO2010091142A1 (en) * 2009-02-04 2010-08-12 President And Fellows Of Harvard College Compositions and methods for labeling and imaging phospholipids
WO2022249113A1 (en) * 2021-05-25 2022-12-01 주식회사 자이메디 Novel compound inhibiting binding between aimp2-dx2 and kras, and use thereof

Also Published As

Publication number Publication date
AU2003278814A8 (en) 2004-04-30
WO2004024939A3 (en) 2004-10-14
WO2004024939A2 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
AU2002335231A1 (en) Activator for peroxisome proliferator-activated receptor delta
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
AU2002323776A1 (en) Activator for peroxisome proliferator-responsive receptor Delta
AU2003233010A1 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
IL160964A0 (en) Peroxisome proliferator activated receptor ligand and process for producing the same
AU2003267728A1 (en) Cannabinoid receptor ligands and uses thereof
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2003278814A1 (en) Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
IL161578A0 (en) Peroxisome proliferator activated receptor agonists
AU2003231352A1 (en) Biocidal formulation and methods for the preparation thereof
AU2003292508A1 (en) N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands
AU2003299648A1 (en) Substituted 4-phenyl-(1,3)-dioxanes
AU2003260984A1 (en) S-(-)-amlodipine nicotinate and process for the preparation thereof
AU2002347985A1 (en) Peroxisome proliferator activated receptor alpha agonists
SI1532141T1 (en) 2-PYRROLIDIN-2-YL- ?á1,3,4?å-OXADIAZOLE DERIVATIVES AND THE USE OF THE SAME AS ANTIDEPRESSANTS
AU2003289176A1 (en) 1,3-benzothiazinone derivatives, process for producing the same and use thereof
TWI348382B (en) N-acetylglucosamine derivatives, and the use thereof
AU2002325164A1 (en) Receptor, the use thereof, and mouse antibodies
AU2003216546A1 (en) Ultrasonic microkeratome
AU2003277665A1 (en) Peroxisome proliferator-activated recetor ligand
AU2003300262A1 (en) Phthalimidylazo dyes, processes for the preparation thereof and the use thereof
AU2003296545A1 (en) Use of a trpm8-activating substance for the treatment of tumours
AU2003281698A1 (en) 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
AU2002335304A1 (en) The use of berberine as insulin sensitizer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase